Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Palatin Technologies’ Obesity Drug Receives FDA Orphan Designation; Phase 2 Results Imminent (NYSE: PTN)
Via AB Newswire
Exposures Product Safety
Tickers PTN
Soleno Shares Are Up Today: What's Going On?
Via Benzinga
Exposures Product Safety
Tickers SLNO
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Viatris Inc. (VTRS)
Via NewMediaWire
Exposures Product Safety
Tickers VTRS
Kaplan Fox &amp; Kilsheimer LLP is Investigating Potential Securities Law Violations Against Viatris Inc. (VTRS)
Via TheNewswire.com
Exposures Product Safety
Tickers VTRS
$300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
Via PRLog
Exposures Product Safety
Penny Stock Equillium Falls After Itolizumab Treatment Fails To Show Improvement In Response Rates In Graft Versus Host Disease Patients
Via Benzinga
Exposures Product Safety
Tickers EQ
Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?
Via Investor's Business Daily
Exposures Product Safety
Tickers GILD MRK REGN VRTX
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at AAPM 2025 PainConnect Meeting
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Soleno Therapeutics Stock Rockets 34% Pre-Market After FDA Approves Prader-Willi Syndrome Drug: Retail Sentiment Peaks
Via Stocktwits
Exposures Product Safety
Tickers SLNO VTI XBI
Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder
Via Benzinga
Exposures Product Safety
Tickers SLNO
Kaplan Fox & Kilsheimer LLP is Investigating Viatris Inc. (VTRS) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers VTRS
Kaplan Fox &amp; Kilsheimer LLP is Investigating Viatris Inc. (VTRS) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers VTRS
Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers HIT LPTX OSRH THTX
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
Via Benzinga
Exposures Product Safety
Tickers BMY EXEL PFE
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
Via Benzinga
Exposures Product Safety
Tickers GSK
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
Via Benzinga
Exposures Product Safety
Tickers WVE
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Begins Final Preclinical Study for PTSD Treatment SPC-15
Via Investor Brand Network
Exposures Product Safety
Tickers SILO
Tenon Medical Stock Rockets Nearly 4x, Leads Retail Follower Surge In Healthcare: What's Driving The Hype?
Via Stocktwits
Exposures Product Safety
Tickers TNON VXF
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers DYAI PNPNF POAI TNON
What's Going On With Tenon Medical Shares Tuesday?
Via Benzinga
Exposures Product Safety
Tickers TNON
Pharma Frenzy: Volatility Ignites Biotech Sector
Via MarketBeat
Exposures Product Safety
Tickers LXEO TNXP
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI BFRG TALK TDOC
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Via Benzinga
Exposures Product Safety
Tickers INBS
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
Expanding Coverage for FDA-Approved GLP-1s Is Critical for Patient Safety
Via NewsUSA
Exposures Product Safety
$300 Million in Milestones; Double-Digit Royalties; LOI with Neurospa for Expansion of International Psychiatry Clinics; NDA Filed with FDA on New Drug: NRx Pharmaceuticals: (Stock Symbol: NRXP)
Via Get News
Exposures Product Safety
Tickers NRXP
Alnylam Pharmaceuticals Presents 'Convincing Multi-Billion Dollar Opportunity': Analyst Upgrades Stock
Via Benzinga
Exposures Product Safety
Tickers ALNY JPM
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Fibromyalgia Drug Without Advisory Committee Review
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Why Tonix Pharmaceuticals (TNXP) Stock Is Rising
Via Benzinga
Exposures Product Safety
Tickers TNXP
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.